Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ФАЗА 2<.>)
Общее количество найденных документов : 533
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
Randomized late phase II study of KW-2307 [vinorelbine, NVB) vs vindesine (VDS) in previously untreated non-small cell lung cancer // Nihon gan chiryo gakkaishi, 1994. Vol. 29, N 2.-С.270

2.
A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma // Cancer, 1994. Vol. 73, N 11.-С.2803-2807

3.
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck // Invest. New Drugs, 1993. Vol. 11, N 2-3.-С.227-229

4.
Phase II study on DuP937 (Teloxantrone) in colorectal carcinoma // Invest. New Drugs, 1993. Vol. 11, N 2-3.-С.235-237

5.
Quan Walter D.Y.Jr. Phase II trial of carbetimer in metastatic melanoma // Invest. New Drugs, 1993. Vol. 11, N 2-3.-С.231-233

6.
Phase II trial of amonafide in advanced pancreas cancer // Invest. New Drugs, 1993. Vol. 11, N 2-3.-С.219-221

7.
An optimal three-stage design for phase II clinical trials // Statist. Med., 1994. Vol. 13, N 17.-С.1727-1736

8.
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer: A phase II trial // Cancer, 1994. Vol. 73 N7.-С.1932-1936

9.
A phase II study of advanced colorectal cancer patients treated with combination 5-fluorouracil plus leucovorin and subcutaneous interleukin-2 plus alpha interferon // J. Chemother., 1994. Vol. 6, N 4.-С.265-271

10.
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy // Cancer, 1994. Vol. 74, N 6.-С.1733-1738

11.
Radiotherapie per-operatoire (RPO) dans les tumeurs malignes cerebrales: etude de phase II (Poster) // Lyon chir, 1994. Vol. 90, N 4.-С.264-265

12.
Single agent paclitaxel in previously untreated patients with stage IV epithelial ovarian cancer: preliminary analysis of a phase II study // Brit. J. Obstet. and Gynaecol., 1995. Vol. 102, N 4.-С.341-342

13.
A phase II study of alternating paclitaxel (175 mg/m{2}) and carboplatin (AUC-7) in patients with advanced inoperable epithelial ovarian cancer // Brit. J. Obstet. and Gynaecol., 1995. Vol. 102, N 4.-С.342

14.
Early phase II study of BMS-181339 (paclitaxel) on non-small cell lung cancer (NSCLC) // Nihon gan chiryo gakkaishi, 1995. Vol. 30, N 2.-С.105

15.
Phase II study of concurrent platinum-vindesine chemotherapy plus accelerated twice-daily radiotherapy for locally non-small cell lung cancer (NSCLC) // Nihon gan chiryo gakkaishi, 1995. Vol. 30, N 2.-С.142

16.
A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma: A childrens cancer group study // Cancer, 1995. Vol. 75, N 12.-С.2959-2965

17.
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma // Cancer, 1995. Vol. 75, N 9.-С.2197-2202

18.
Phase II study on neoadjuvant hyperthermic - antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomeas // Cancer, 1994. Vol. 73, N 8.-С.2140-2146

19.
Phase II study on neoadjuvant hyperthermic - antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomeas // Cancer, 1994. Vol. 73, N 8.-С.2140-2146

20.
A phase II study of combined chemotherapy using Pirarubicin(THP), methotrexate(MTX) and 5-fluorouracil(5FU) for advanved or recurrent gastric cancinoma // Nihon gan chiryo gakkaishi, 1995. Vol. 30, N 2.-С.376

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)